RE: Jupiter.8 Feb 2022 09:26
I think the main issue in the forseeable for many PI's is the lack of IMMINENT sp catalysts. I can't see us getting any more substantial updates from the therapeutics side for a few months, hence my comment earlier about the sp slowly getting lower. It happens each time and each time it happens, the boards have their usual rampers (and derampers) claiming it won't. Remove the rose tinted glasses, the therapeutics business has lots and lots of potential, but don't expect £1+ in this half of the year. Learn from mistakes, as I am trying to do.